Ciamexon (Ciamexone) is a novel immunomodulator that has shown promising results in experimental models of autoimmune disease with little demonstrated cytotoxicity.Ciamexon can be used to study endocrine ophthalmopathies and diabetes mellitus, with slight improvement in ophthalmic disease following short-term administration.

7-羟基异黄酮在体外对抗肠道病毒 71。

APL1β27 trifluoroacetate salt/APLP1-derived Aβ-like peptide (1-27)